Skip to main content
. 2016 Oct;22(10):10.18553/jmcp.2016.22.10.1186. doi: 10.18553/jmcp.2016.22.10.1186

TABLE 1.

Characteristics of Index Admissions with or Without Receipt of PCE-C or PCE-D

Visit Variables, N = 375 Admissions Received Systemic Corticosteroid Within 14 Days of Discharge (PCE-C) Received Bronchodilator Within 30 Days of Discharge (PCE-D)
Yes
n = 254 (68%)
No
n = 121 (32%)
P Value Yes
n = 299 (80%)
No
n = 76 (20%)
P Value
Pre-Index Variables
Age 60 (7) 58 (8) 0.312 60 (7) 57 (8) 0.012
Gender
 Female 168 (70%) [66%] 72 (30%) [60%] 0.211 192 (80%) [64%] 48 (20%) [63%] 0.864
 Male 86 (64%) [34%] 49 (36%) [40%] 107 (79%) [36%] 28 (21%) [37%]
Charlson Comorbidity Index 1.68 (1.31) 1.82 (1.63) 0.403 1.69 (1.34) 1.84 (1.7) 0.474
On a rescue medication
 Yes 224 (73%) [88%] 84 (27%) [69%] < 0.001 262 (85%) [88%] 46 (15%) [61%] < 0.001
 No 30 (45%) [12%] 37 (55%) [31%] 37 (55%) [12%] 30 (45%) [39%]
Number of rescue medicationsa 6.19 (7.27) 4.17 (6.82) 0.011 6.57 (7.61) 1.46 (2.38) < 0.001
On a maintenance medication
 Yes 164 (73%) [65%] 60 (27%) [50%] 0.005 195 (87%) [65%] 29 (13%) [38%] < 0.001
 No 90 (60%) [35%] 61 (40%) [50%] 104 (69%) [35%] 47 (31%) [62%]
Number of maintenance medicationsa 4.59 (6.17) 3.01 (4.92) 0.008 4.88 (6.21) 0.93 (1.99) < 0.001
Proportion of days covered 0.29 (0.34) 0.2 (0.3) 0.012 0.31 (0.34) 0.07 (0.15) < 0.001
 PDC ≥ 75% 40 (77%) [16%] 12 (23%) [10%] 0.017 51 (98%) [17%] 1 (2%) [1%] < 0.001
 PDC < 75% 124 (72%) [49%] 48 (28%) [40%] 144 (84%) [48%] 28 (16%) [37%]
 No maintenance drug 90 (60%) [35%] 61 (40%) [50%] 104 (69%) [35%] 47 (31%) [62%]
Total medical + pharmacy costs, $ 18,718 (23,056) 25,838 (39,890) 0.280 20,180 (29,378) 24,304 (30,846) 0.070
 COPD-related, $ 3,492 (5,078) 3,373 (6,422) 0.135 3,713 (5,104) 2,434 (6,941) 0.858
Total medical costs, $ 15,126 (22,383) 22,971 (39,231) 0.042 16,624 (28,847) 21,723 (29,874) 0.173
 Inpatient costs, $ 7,665 (16,199) 14,026 (32,812) 0.045 9,228 (23,580) 11,645 (20,929) 0.415
  COPD-related, $ 1,178 (3,391) 1,908 (5,827) 0.202 1,329 (3,533) 1,746 (6,629) 0.598
 Outpatient costs, $ 5,330 (7,805) 6,748 (9,666) 0.161 5,272 (7,657) 7,818 (10,908) 0.058
  COPD-related, $ 398 (1,246) 291 (617) 0.268 401 (1,195) 215 (392) 0.025
Total pharmacy costs, $ 3,591 (3,629) 2,865 (3,306) 0.063 3,554 (3,438) 2,579 (3,840) 0.105
 COPD-related, $ 1,474 (1,886) 941 (1,361) 0.002 1,569 (1,856) 251 (416) < 0.001
Total inpatient visits 1.46 (2.1) 2.00 (2.83) 0.062 1.5 (2.12) 2.16 (3.15) 0.087
 COPD-related 0.32 (0.75) 0.36 (0.9) 0.700 0.32 (0.8) 0.36 (0.81) 0.764
Total outpatient visits 9.82 (7.96) 9.17 (7.81) 0.461 9.47 (7.79) 10.16 (8.37) 0.500
 COPD-related 1.35 (2.32) 1.2 (2.29) 0.542 1.36 (2.43) 1.07 (1.73) 0.221
COPD exacerbationsb 0.80 (1.64) 0.45 (1.03) 0.010 0.73 (1.58) 0.50 (0.96) 0.110
Event (Index) Variables
Length of stay, days 1.92 (2.35) 1.56 (3.54) 0.312 1.90 (2.88) 1.45 (2.37) 0.161
Cost of hospitalization/ED, $ 4,491 (4,346) 4,503 (10,160) 0.990 4,511 (6,962) 4,430 (6,022) 0.926
Location
 ED 131 (63%) [52%] 78 (37%) [64%] 0.019 160 (77%) [54%] 49 (23%) [64%] 0.086
 Inpatient hospital 123 (74%) [48%] 43 (26%) [36%] 139 (84%) [46%] 27 (16%) [36%]

Note: Expressed as mean (SD) for continuous variables or count (Row %) [Column %] for categorical variables.

a Number of medications are expressed as mean inhalers per patient per year and include patients who have no medications.

b COPD exacerbations were defined as an inpatient hospitalization or an ED visit with a primary diagnosis for COPD or a claim for oral or parenteral corticosteroids within 7 days following an outpatient claim for COPD, expressed as per patient per year.

COPD = chronic obstructive pulmonary disease; ED = emergency department; PCE = pharmacotherapy management of COPD exacerbation; PDC = proportion of days covered; SD = standard deviation.